Lyell Immunopharma, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
LYEL$15.42+3.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber | Description | Form | File Number | Exhibit/AppendixReference | FilingDate | FiledHerewith |
|---|---|---|---|---|---|---|
| 2.1 | Agreement and Plan of Merger, dated as of October 24, 2024, by and among the Registrant, ImmPACT Bio USA Inc., Inspire Merger Sub Inc. and WT Representative LLC, solely in its capacity as the Representative. | 8-K | 001-40502 | 2.1 | 10/24/2024 | |
| 3.1 | Amended and Restated Certificate of Incorporation. | S-8 | 333-257249 | 4.1 | 06/21/2021 | |
| 3.2 | Certificate of Amendment of the Amended and Restated Certificate of Incorporation of Lyell Immunopharma, Inc. | 8-K | 001-40502 | 3.1 | 05/28/2025 | |
| 3.3 | Amended and Restated Bylaws. | 8-K | 001-40502 | 3.1 | 12/05/2025 | |
| 4.1 | Form of Common Stock Certificate. | 10-Q | 001-40502 | 4.1 | 08/12/2025 | |
| 4.2 | Amended and Restated Investors' Rights Agreement, by and among the Registrant and certain of its stockholders, dated March 5, 2020. | S-1 | 333-256470 | 4.2 | 05/25/2021 | |
| 10.1# | Offer Letter by and between the Registrant and Smital Shah, dated March 3, 2026. | 8-K | 001-40502 | 10.1 | 03/09/2026 | |
| 10.2*# | Lyell Immunopharma, Inc. Non-Employee Director Compensation Policy | X | ||||
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a). | X | ||||
| 31.2 | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a). | X | ||||
| 32.1« | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350. | X | ||||
| 101.INS | XBRL Instance Document. | The XBRL instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | X | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | X | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | X | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.